GGrantIndex
Sort

25,944 grants matching neurodegeneration

Molecular tools for cholesterol metabolite signaling

$393,720
Alison Evelynn Ondrus · University Of Illinois At Chicago · R35 · FY2025 · GM

TRANSGENIC MODELS TO SUDY ALZHEIMERS DISEASE

$393,715
J. David Gladstone Institutes · R01 · FY2000 · AG

AIDS-RELATED NEUROTOXCITY: GP120 AND CHEMOKINES

$393,691
Burnham Institute For Medical Research · R01 · FY2001 · EY

NOX2 drives microglia-dependent neurodegeneration after traumatic brain injury

$393,683
Bogdan Adrian Stoica · University Of Maryland Baltimore · R01 · FY2023 · NS

Gene Interaction in Development and Disease

$393,646
Miriam H Meisler · University Of Michigan At Ann Arbor · R01 · FY2011 · GM

Structural basis for ApoE4-induced Alzheimer's disease

$393,634
Gregory Bowman · Washington University · RF1 · FY2021 · AG

Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9

$393,625
Le Cong · Stanford University · R35 · FY2021 · HG

Argininosuccinate Lyase is an essential regulator of systemic nitric oxide produc

$393,625
Brendan Hl Lee · Baylor College Of Medicine · R01 · FY2009 · GM

Clinically Relevant Biomarkers for Niemann-Pick Type C

$393,623
Stephanie M Cologna · University Of Illinois At Chicago · U01 · FY2025 · FD

Defining the role of phosphatidic acid as an allosteric regulator of mitochondrial glutaminase

$393,600
Michael Lukey · Cold Spring Harbor Laboratory · R01 · FY2025 · GM

Defining the role of phosphatidic acid as an allosteric regulator of mitochondrial glutaminase

$393,600
Michael Lukey · Cold Spring Harbor Laboratory · R01 · FY2024 · GM

Defining the role of phosphatidic acid as an allosteric regulator of mitochondrial glutaminase

$393,600
Michael Lukey · Cold Spring Harbor Laboratory · R01 · FY2023 · GM

Cell Signaling and Neurodegeneration

$393,599
Harry T. Orr · University Of Minnesota · R01 · FY2021 · NS

Cell Signaling and Neurodegeneration

$393,599
Harry T. Orr · University Of Minnesota · R01 · FY2019 · NS

Cell Signaling and Neurodegeneration

$393,599
Harry T. Orr · University Of Minnesota · R01 · FY2020 · NS

Human iPSC neuronal models for early and late phases of FXTAS neurodegeneration

$393,544
Paul J Hagerman · University Of California At Davis · RC1 · FY2009 · AG

Molecular Assessment of Cause and Consequence of Cellular Senescence in Diverse Midbrain Cell Types in Parkinson's Disease

$393,539
Markus Riessland · State University New York Stony Brook · R01 · FY2022 · NS

Molecular Assessment of Cause and Consequence of Cellular Senescence in Diverse Midbrain Cell Types in Parkinson's Disease

$393,539
Markus Riessland · State University New York Stony Brook · R01 · FY2025 · NS

Molecular Assessment of Cause and Consequence of Cellular Senescence in Diverse Midbrain Cell Types in Parkinson's Disease

$393,539
Markus Riessland · State University New York Stony Brook · R01 · FY2023 · NS

Mitochondrial Fission and Neuronal Cell Death

$393,534
Burnham Institute For Medical Research · R01 · FY2003 · NS

Project 4: Pesticides and Genes In PD: Studies In Humans

$393,449
Beate R Ritz · University Of California Los Angeles · P01 · FY2010 · ES

Molecular Basis of rCGG-Mediated Neurodegeneration

$393,435
David Loren Nelson · Baylor College Of Medicine · R01 · FY2022 · NS

Molecular Basis of rCGG-Mediated Neurodegeneration

$393,435
David Loren Nelson · Baylor College Of Medicine · R01 · FY2021 · NS

Molecular Basis of rCGG-Mediated Neurodegeneration

$393,435
David Loren Nelson · Baylor College Of Medicine · R01 · FY2023 · NS

Identification of Inhibitory Compounds for Apaf-1 by High Throughput Screening

$393,420
Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA